Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Thyrocare Technologies Ltd ( (IN:THYROCARE) ) has provided an announcement.
Thyrocare Technologies Limited announced that it has received two major recognitions at the 4th Edition of the National Diagnostics Forum & Awards 2026, organized by Voice of Healthcare in Mumbai. The company was named “Best Diagnostic Lab Chain of the Year” and “Patient-Centric Diagnostic Company of the Year,” underscoring its strategic positioning as a leading, customer-focused diagnostics provider and reinforcing its reputation for quality, affordability, and operational excellence in India’s competitive diagnostics market.
More about Thyrocare Technologies Ltd
Thyrocare Technologies Limited is a diagnostics company operating a chain of laboratories that provide a wide range of medical testing and diagnostic services. The company focuses on delivering good quality and affordable diagnostics across India, with an emphasis on patient-centric care, innovation, and operational efficiency in the healthcare diagnostics industry.
Average Trading Volume: 60,373
Technical Sentiment Signal: Buy
Current Market Cap: 75.48B INR
See more data about THYROCARE stock on TipRanks’ Stock Analysis page.